Vacca A - Search Results

1

Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.

Basile A, Moschetta M, Ditonno P, Ria R, Marech I, De Luisi A, Berardi S, Frassanito MA, Angelucci E, Derudas D, Specchia G, Curci P, Pavone V, Rossini B, Ribatti D, Bottazzi B, Mantovani A, Presta M, Dammacco F, Vacca A. Basile A, et al. Among authors: vacca a. J Pathol. 2013 Jan;229(1):87-98. doi: 10.1002/path.4081. Epub 2012 Oct 1. J Pathol. 2013. PMID: 22847671 Free article.

2

In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF.

Valdembri D, Serini G, Vacca A, Ribatti D, Bussolino F. Valdembri D, et al. Among authors: vacca a. FASEB J. 2002 Feb;16(2):225-7. doi: 10.1096/fj.01-0633fje. Epub 2001 Dec 14. FASEB J. 2002. PMID: 11744626

3

Endothelial cell heterogeneity and organ specificity.

Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F. Ribatti D, et al. Among authors: vacca a. J Hematother Stem Cell Res. 2002 Feb;11(1):81-90. doi: 10.1089/152581602753448559. J Hematother Stem Cell Res. 2002. PMID: 11847005 Review.

4

Docetaxel versus paclitaxel for antiangiogenesis.

Vacca A, Ribatti D, Iurlaro M, Merchionne F, Nico B, Ria R, Dammacco F. Vacca A, et al. J Hematother Stem Cell Res. 2002 Feb;11(1):103-18. doi: 10.1089/152581602753448577. J Hematother Stem Cell Res. 2002. PMID: 11847007

5

Is thalidomide a true anti-angiogenic molecule in multiple myeloma?

Ribatti D, Vacca A. Ribatti D, et al. Among authors: vacca a. Haematologica. 2002 Apr;87(4):344-5. Haematologica. 2002. PMID: 11940476 No abstract available.

6

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.

Tosi P, Zamagni E, Cellini C, Ronconi S, Patriarca F, Ballerini F, Musto P, Di Raimondo F, Ledda A, Lauria F, Masini L, Gobbi M, Vacca A, Ria R, Cangini D, Tura S, Baccarani M, Cavo M. Tosi P, et al. Among authors: vacca a. Haematologica. 2002 Apr;87(4):408-14. Haematologica. 2002. PMID: 11940485 Clinical Trial.

7

Angiogenic activity of rat mast cells in the chick embryo chorioallantoic membrane is down-regulated by treatment with recombinant human alpha-2a interferon and partly mediated by fibroblast growth factor-2.

Ribatti D, Crivellato E, Candussio L, Vacca A, Nico B, Benagiano V, Roncali L, Dammacco F. Ribatti D, et al. Among authors: vacca a. Haematologica. 2002 May;87(5):465-71. Haematologica. 2002. PMID: 12010658

8

In situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane.

Ribatti D, Cruz A, Nico B, Favier J, Vacca A, Corsi P, Roncali L, Dammacco F. Ribatti D, et al. Among authors: vacca a. Cytokine. 2002 Mar 7;17(5):262-5. doi: 10.1006/cyto.2002.1002. Cytokine. 2002. PMID: 12027407

9

Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.

Ria R, Vacca A, Ribatti D, Di Raimondo F, Merchionne F, Dammacco F. Ria R, et al. Among authors: vacca a. Haematologica. 2002 Aug;87(8):836-45. Haematologica. 2002. PMID: 12161360

10

Cross-talk between hematopoiesis and angiogenesis signaling pathways.

Ribatti D, Vacca A, Nico B, Ria R, Dammacco F. Ribatti D, et al. Among authors: vacca a. Curr Mol Med. 2002 Sep;2(6):537-43. doi: 10.2174/1566524023362195. Curr Mol Med. 2002. PMID: 12243246 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

907 results

Search Page